CD28 and neoplasm: As shown in Figure 3A, engagement of the antigen-specific TCR and CD28 costimulatory molecule by tumor cells or antigen-presenting cells triggers a T cell signaling cascade involving ZAP70, PI3K, and RAS pathways (7).